These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 29428498

  • 1. The role of gut microbiota in Clostridium difficile infection.
    Samarkos M, Mastrogianni E, Kampouropoulou O.
    Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
    Zhang L, Dong D, Jiang C, Li Z, Wang X, Peng Y.
    Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE, van Beurden YH, Terveer EM, Goorhuis A, Bauer MP, Keller JJ, Mulder CJJ, Kuijper EJ.
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [Abstract] [Full Text] [Related]

  • 6. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection.
    Džunková M, D'Auria G, Xu H, Huang J, Duan Y, Moya A, Kelly CP, Chen X.
    Front Cell Infect Microbiol; 2016 May; 6():119. PubMed ID: 27757389
    [Abstract] [Full Text] [Related]

  • 7. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC, Koziel J, Dieterich W, Haziri D, Wirtz S, Glowczyk I, Konturek K, Neurath MF, Zopf Y.
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [Abstract] [Full Text] [Related]

  • 8. Prevention and treatment of Clostridium difficile associated diarrhea by reconstitution of the microbiota.
    Eliakim-Raz N, Bishara J.
    Hum Vaccin Immunother; 2019 Dec; 15(6):1453-1456. PubMed ID: 29781761
    [Abstract] [Full Text] [Related]

  • 9. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR, Flemer B, Joyce SA, Zulquernain A, Sheehan D, Shanahan F, O'Toole PW.
    BMC Gastroenterol; 2018 Aug 28; 18(1):131. PubMed ID: 30153805
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M, Khair S, Grewal S, LaComb JF, Park J, Channer B, Rajapakse R, Bucobo JC, Buscaglia JM, Monzur F, Chawla A, Yang J, Robertson CE, Frank DN, Li E.
    PLoS One; 2018 Aug 28; 13(1):e0190997. PubMed ID: 29385143
    [Abstract] [Full Text] [Related]

  • 11. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.
    Battaglioli EJ, Hale VL, Chen J, Jeraldo P, Ruiz-Mojica C, Schmidt BA, Rekdal VM, Till LM, Huq L, Smits SA, Moor WJ, Jones-Hall Y, Smyrk T, Khanna S, Pardi DS, Grover M, Patel R, Chia N, Nelson H, Sonnenburg JL, Farrugia G, Kashyap PC.
    Sci Transl Med; 2018 Oct 24; 10(464):. PubMed ID: 30355801
    [Abstract] [Full Text] [Related]

  • 12. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
    Carlucci C, Petrof EO, Allen-Vercoe E.
    EBioMedicine; 2016 Nov 24; 13():37-45. PubMed ID: 27720396
    [Abstract] [Full Text] [Related]

  • 13. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
    Piekarska A, Panasiuk A, Stępień PM.
    Przegl Epidemiol; 2020 Nov 24; 74(1):69-87. PubMed ID: 32500988
    [Abstract] [Full Text] [Related]

  • 14. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Zuo T, Wong SH, Cheung CP, Lam K, Lui R, Cheung K, Zhang F, Tang W, Ching JYL, Wu JCY, Chan PKS, Sung JJY, Yu J, Chan FKL, Ng SC.
    Nat Commun; 2018 Sep 10; 9(1):3663. PubMed ID: 30202057
    [Abstract] [Full Text] [Related]

  • 15. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
    Khoruts A.
    Expert Rev Gastroenterol Hepatol; 2018 May 10; 12(5):435-438. PubMed ID: 29667436
    [No Abstract] [Full Text] [Related]

  • 16. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J, Mattila E, Jouhten H, Hartman J, de Vos WM, Arkkila P, Satokari R.
    BMC Med; 2016 Oct 11; 14(1):155. PubMed ID: 27724956
    [Abstract] [Full Text] [Related]

  • 17. Clostridium difficile infection and intestinal microbiota interactions.
    Rodriguez C, Taminiau B, Van Broeck J, Delmée M, Daube G.
    Microb Pathog; 2015 Dec 11; 89():201-9. PubMed ID: 26549493
    [Abstract] [Full Text] [Related]

  • 18. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
    Ianiro G, Valerio L, Masucci L, Pecere S, Bibbò S, Quaranta G, Posteraro B, Currò D, Sanguinetti M, Gasbarrini A, Cammarota G.
    Clin Microbiol Infect; 2017 May 11; 23(5):337.e1-337.e3. PubMed ID: 28057560
    [Abstract] [Full Text] [Related]

  • 19. Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients.
    Bruno G, Gagliardi A, Oliva A, Trancassini M, Macone A, Cicerone C, D'Abramo A, Iebba V, Auria S, Bonfiglio G, Zingaropoli MA, D'Ettorre G, Badiali D, Vullo V, Corazziari ES, Schippa S.
    New Microbiol; 2019 Oct 11; 42(4):221-224. PubMed ID: 31609455
    [Abstract] [Full Text] [Related]

  • 20. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G, Maraolo AE, Foggia M, Buonomo AR, Gentile I.
    Expert Opin Biol Ther; 2015 Jul 11; 15(7):1001-14. PubMed ID: 26063385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.